Cellectis (CLLS) Operating Expenses (2015 - 2026)

Cellectis' Operating Expenses history runs 12 years deep, the most recent figure standing at -$32.7 million for Q1 2026.

• On a quarterly basis, Operating Expenses fell 24.83% year-over-year to -$32.7 million in Q1 2026; TTM through Mar 2026 was -$119.2 million, a 10165.46% decrease from a year earlier, with the FY2025 full-year figure at -$112.7 million, changed N/A from the prior year.
• Operating Expenses slipped to -$32.7 million in Q1 2026 per CLLS's latest filing, from -$29.6 million in the prior quarter.
• Across five years, Operating Expenses topped out at $85.9 million in Q4 2023 and bottomed at -$33.0 million in Q1 2022.
• The 5-year median for Operating Expenses is -$27.4 million (2024), against an average of -$14.7 million.
• Across the five-year window, Operating Expenses jumped 473.64% in 2023 and plunged 135.64% in 2025, its largest moves.
• Year by year, Operating Expenses stood at -$23.0 million in 2022, then soared by 473.64% to $85.9 million in 2023, then slipped by 3.43% to $82.9 million in 2024, then plunged by 135.64% to -$29.6 million in 2025, then retreated by 10.68% to -$32.7 million in 2026.
• Per Business Quant, the three latest CLLS Operating Expenses figures stand at -$32.7 million (Q1 2026), -$29.6 million (Q4 2025), and -$29.1 million (Q3 2025).